Showing results (411-420 of 3,386) with videos related to
Sort By:
Pageof 339
CNS Neuroscience & Therapeutics|October 19, 2010
Lacosamide and epilepsyJacklyn A Harris, Julie A MurphyCNS Neuroscience & Therapeutics|November 6, 2010
REVIEW: Patient, treatment, and systems-level factors in bipolar disorder nonadherence: A summary of the literatureKatherine Kovalski Busby, Martha SajatovicCNS Neuroscience & Therapeutics|March 14, 2013
The emerging use of ketamine for anesthesia and sedation in traumatic brain injuriesLee C Chang, Sally R Raty, Jaime Ortiz, et al.CNS Neuroscience & Therapeutics|March 16, 2013
The disturbance of hippocampal CaMKII/PKA/PKC phosphorylation in early experimental diabetes mellitusMei-Hua Liao, Ying-Chun Xiang, Ji-Yun Huang, et al.CNS Neuroscience & Therapeutics|February 15, 2013
Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-κB and NLRP3 inflammasome activationJian-Quan Shi, Chu-Chu Zhang, Xiu-Lan Sun, et al.CNS Neuroscience & Therapeutics|February 28, 2013
Effects of combination therapy with levamlodipine and bisoprolol on stroke in ratsHuan Gui, Yong-Fei Guo, Xia Liu, et al.CNS Neuroscience & Therapeutics|April 16, 2013
Zinc promotes the death of hypoxic astrocytes by upregulating hypoxia-induced hypoxia-inducible factor-1alpha expression via poly(ADP-ribose) polymerase-1Rong Pan, Chen Chen, Wen-Lan Liu, et al.CNS Neuroscience & Therapeutics|April 19, 2013
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?Zaira Esposito, Lorena Belli, Sofia Toniolo, et al.CNS Neuroscience & Therapeutics|March 7, 2013
High-dose donepezil (23 mg/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelinesJeffrey L Cummings, David Geldmacher, Martin Farlow, et al.CNS Neuroscience & Therapeutics|March 7, 2013
Preclinical assessment of ketamineCheng Wang, Fang Liu, Tucker A Patterson, et al.Pageof 339